The Clozapine Handbook: Stahl's Handbooks

Jonathan M. Meyer; Stephen M. Stahl

doi:10.1017/9781108553575

The Clozapine Handbook

Stahl's Handbooks

- Get access
  
  Buy a print copy
  
  Check if you have access via personal or institutional login
  
  Log in Register
Cited by 49
Cited by
- 49
Crossref Citations

This Book has been cited by the following publications. This list is generated based on data provided by Crossref.

Schoretsanitis, Georgios Kane, John M. Ruan, Can-Jun Spina, Edoardo Hiemke, Christoph and de Leon, Jose 2019. A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients. Expert Review of Clinical Pharmacology, Vol. 12, Issue. 7, p. 603.

CrossRef

Google Scholar

Cummings, Michael A. Scott, Charles Arguello, Juan Carlos Arias, Ai-Li W. Breth, Ashley M. Delgado, Darci Harvey, Phil D. Meyer, Jonathan M. O’Day, Jennifer Pollock, Megan Proctor, George Rector, Tiffany Rose, Benjamin Schwartz, Eric Thordarson, Helga Warburton, Katherine and Stahl, Stephen M. 2020. The Cal-DSH diversion guidelines. CNS Spectrums, Vol. 25, Issue. 5, p. 701.

CrossRef

Google Scholar

Casetta, Cecilia Oloyede, Ebenezer Whiskey, Eromona Taylor, David Michael Gaughran, Fiona Shergill, Sukhi S. Onwumere, Juliana Segev, Aviv Dzahini, Olubanke Legge, Sophie E. and MacCabe, James Hunter 2020. A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis. The British Journal of Psychiatry, Vol. 217, Issue. 3, p. 506.

CrossRef

Google Scholar

Hariman, Keith Cheng, Koi Man Lam, Jenny Leung, Siu Kau and Lui, Simon S. Y. 2020. Clinical risk model to predict 28-day unplanned readmission via the accident and emergency department after discharge from acute psychiatric units for patients with psychotic spectrum disorders. BJPsych Open, Vol. 6, Issue. 1,

CrossRef

Google Scholar

Meyer, Jonathan M. 2020. Monitoring and improving antipsychotic adherence in outpatient forensic diversion programs. CNS Spectrums, Vol. 25, Issue. 2, p. 136.

CrossRef

Google Scholar

Rubio, J. M. and Kane, J. M. 2020. How and when to use clozapine. Acta Psychiatrica Scandinavica, Vol. 141, Issue. 3, p. 178.

CrossRef

Google Scholar

2020. Prescriber's Guide. p. 191.

CrossRef

Google Scholar

Stahl, Stephen M. 2020. Prescriber's Guide.

CrossRef

Google Scholar

Oloyede, Ebenezer Casetta, Cecilia Dzahini, Olubanke Segev, Aviv Gaughran, Fiona Shergill, Sukhi Mijovic, Alek Helthuis, Marinka Whiskey, Eromona MacCabe, James Hunter and Taylor, David 2021. There Is Life After the UK Clozapine Central Non-Rechallenge Database. Schizophrenia Bulletin, Vol. 47, Issue. 4, p. 1088.

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. 87.

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. 249.

CrossRef

Google Scholar

Blackman, Graham and Oloyede, Ebenezer 2021. Clozapine discontinuation withdrawal symptoms in schizophrenia. Therapeutic Advances in Psychopharmacology, Vol. 11, Issue. ,

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. 60.

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. 296.

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. 147.

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. 13.

CrossRef

Google Scholar

2021. Suicide Prevention. p. 149.

CrossRef

Google Scholar

Paribello, Pasquale Manchia, Mirko Zedda, Massimo Pinna, Federica and Carpiniello, Bernardo 2021. Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature. Medicina, Vol. 57, Issue. 8, p. 816.

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. xiii.

CrossRef

Google Scholar

2021. The Clinical Use of Antipsychotic Plasma Levels. p. 241.

CrossRef

Google Scholar

Download full list

Jonathan M. Meyer, University of California, San Diego, Stephen M. Stahl, University of California, San Diego

Publisher:: Cambridge University Press
Online publication date:: October 2021
Print publication year:: 2019
Online ISBN:: 9781108553575
DOI:: https://doi.org/10.1017/9781108553575

Series:: Stahl's Essential Psychopharmacology Handbooks
Subjects:: Psychiatry and Clinical Psychology, Medicine, Psychiatry

Information

Contents

Metrics

Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management, as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals.

Metrics

Altmetric attention score

Total number of HTML views: 0

Total number of PDF views: 0 *

Loading metrics...

Total views: 0 *

Loading metrics...

* Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

The Clozapine Handbook

Stahl's Handbooks

This Book has been cited by the following publications. This list is generated based on data provided by Crossref.

Book description

Refine List

Actions for selected content:

Contents

The Clozapine Handbook
pp i-ii

The Clozapine Handbook - Title page
pp iii-iii

Copyright page
pp iv-iv

Additional material
pp v-vi

Contents
pp vii-viii

Foreword
pp ix-xii

Introduction
pp 1-9

1 - The Efficacy Story: Treatment-Resistant Schizophrenia, Psychogenic Polydipsia, Treatment-Intolerant Schizophrenia, Suicidality, Violence, Mania and Parkinson’s Disease Psychosis
pp 10-43

2 - Addressing Clozapine Positive Symptom Nonresponse in Schizophrenia Spectrum Patients
pp 44-59

3 - Initiating Clozapine
pp 60-77

4 - Discontinuing Clozapine and Management of Cholinergic Rebound
pp 78-89

5 - Binding Profile, Metabolism, Kinetics, Drug Interactions and Use of Plasma Levels
pp 90-113

6 - Understanding Hematologic Monitoring and Benign Ethnic Neutropenia
pp 114-139

7 - Managing Constipation
pp 140-157

8 - Managing Sedation, Orthostasis and Tachycardia
pp 158-171

9 - Managing Sialorrhea
pp 172-189

10 - Managing Seizure Risk and Stuttering
pp 190-203

11 - Managing Metabolic Adverse Effects
pp 204-223

12 - Fever, Myocarditis, Interstitial Nephritis, DRESS, Serositis and Cardiomyopathy
pp 224-241

13 - Managing Enuresis and Incontinence, Priapism, Venous Thromboembolism, Neuroleptic Malignant Syndrome, Tardive Dyskinesia and Obsessive Compulsive Disorder
pp 242-257

14 - Eosinophilia, Leukocytosis, Thrombocytopenia, Thrombocytosis, Anemia, Hepatic Function Abnormalities
pp 258-275

15 - Special Topics: Child and Adolescent Patients, Elderly Patients, Patients With Intellectual Disability, Pregnancy and Risk for Major Congenital Malformation, Lactation, Overdose, Postmortem Redistribution
pp 276-306

Index
pp 307-318

Metrics

Altmetric attention score

Full text views

Book summary page views

The Clozapine Handbook

Stahl's Handbooks

Book description

Refine List

Actions for selected content:

Save Search

Contents

Metrics

Altmetric attention score

Full text views

Book summary page views